Concepedia

Publication | Open Access

Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study

10

Citations

14

References

2024

Year

Abstract

NCT03395197.

References

YearCitations

Page 1